• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Integrated Wellness Acquisition Corp (WEL)
	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014	Q4-CY2013
Balance Sheet Date		2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31	2023-Sep-30	2023-Jun-30	2023-Mar-31	2022-Dec-31
Fiscal Period		Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024	Q1-FY2024	Q4-FY2023	Q3-FY2023	Q2-FY2023	Q1-FY2023	Q4-FY2022
Total Revenue
QoQ%
YoY%
Cost Of Revenue
Gross Profit
Gross Margin
Operating Expenses		420,952$	140,344$	405,678$	349,080$	558,200$	602,104$	560,614$	274,373$	412,058$	718,960$	1,092,527$	400,423$	205,556$	277,424$	240,969$	497,078$
Operating Income		(420,952$)	(140,344$)	(405,678$)	(349,080$)	(558,200$)	(602,104$)	(560,614$)	(274,373$)	(412,058$)	(718,960$)	(1,092,527$)	(400,423$)	(205,556$)	(277,424$)	(240,969$)
Operating Margin
Interest Income									874,727$	797,857$	1,398,168$	806,553$	831,161$	315,343$	154,851$	11,780$
Interest Expenses
Income Before Tax		(302,631$)	(24,353$)	(292,501$)	39,949$	(24,472$)	(78,378$)	(37,130$)	461,084$	344,075$	(859,532$)	173,235$	809,516$	109,787$	(122,573$)	(229,189$)
Tax Expenses
Net Income		(302,631$)	(24,353$)	(292,501$)	39,949$	(24,472$)	(78,378$)	(37,130$)	461,084$	344,075$	(859,532$)	173,235$	809,516$	109,787$	(122,573$)	(229,189$)
Profit Margin
TTM
Earnings to Minority											(1,372,594$)
Earnings to Common Shareholders		(302,631$)	(24,353$)	(292,501$)	39,949$	(24,472$)	(78,378$)	(37,130$)	461,084$	344,075$	513,062$	173,235$	809,516$	109,787$	(122,573$)	(229,189$)
QoQ%		(1,142.69%)	91.67%	(832.19%)	263.24%	68.78%	(111.09%)	(108.05%)	34.01%	(32.94%)	196.17%	(78.60%)	637.35%	189.57%	46.52%
YoY%		(1,136.64%)	68.93%	(687.78%)	(91.34%)	(107.11%)	(115.28%)	(121.43%)	(43.04%)	213.40%	518.58%	175.59%
Earnings Per Share, Basic
Earnings Per Share, Diluted
Unlevered FCF Per Share, Basic
Unlevered FCF Per Share, Diluted
Average Shares, Basic
Average Shares, Diluted
EBIT		(302,631$)	(24,353$)	(292,501$)	39,949$	(24,472$)	(78,378$)	(37,130$)	461,084$	344,075$	(859,532$)	173,235$	809,516$	109,787$	(122,573$)	(229,189$)
EBITDA		(302,631$)	(24,353$)	(292,501$)	39,949$	(24,472$)	(78,378$)	(37,130$)	461,084$	344,075$	(859,532$)	173,235$	809,516$	109,787$	(122,573$)	(229,189$)

Copy Table ✓